It has also been noted that the patients with pancreatic tumours expressing a strong HIF-1α level had a shorter period until disease recurrence as compared with those with a weak HIF-1α expression underlining the importance of also targeting the HIF signalling network to kill hypoxic pancreatic cancer cells [12]. This evidence concerns the gene HIF1A and pancreatic neoplasm.